657 related articles for article (PubMed ID: 29112693)
1. Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: An economic modelling study.
Rudgard WE; Evans CA; Sweeney S; Wingfield T; Lönnroth K; Barreira D; Boccia D
PLoS Med; 2017 Nov; 14(11):e1002418. PubMed ID: 29112693
[TBL] [Abstract][Full Text] [Related]
2. The economic effects of supporting tuberculosis-affected households in Peru.
Wingfield T; Tovar MA; Huff D; Boccia D; Montoya R; Ramos E; Lewis JJ; Gilman RH; Evans CA
Eur Respir J; 2016 Nov; 48(5):1396-1410. PubMed ID: 27660507
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with catastrophic total costs due to tuberculosis under a designated hospital service model: a cross-sectional study in China.
Yang T; Chen T; Che Y; Chen Q; Bo D
BMC Public Health; 2020 Jun; 20(1):1009. PubMed ID: 32586305
[TBL] [Abstract][Full Text] [Related]
4. Catastrophic costs among tuberculosis-affected households in Zimbabwe: A national health facility-based survey.
Timire C; Ngwenya M; Chirenda J; Metcalfe JZ; Kranzer K; Pedrazzoli D; Takarinda KC; Nguhiu P; Madzingaidzo G; Ndlovu K; Mapuranga T; Cornell M; Sandy C
Trop Med Int Health; 2021 Oct; 26(10):1248-1255. PubMed ID: 34192392
[TBL] [Abstract][Full Text] [Related]
5. Effect of financial support on reducing the incidence of catastrophic costs among tuberculosis-affected households in Indonesia: eight simulated scenarios.
Fuady A; Houweling TAJ; Mansyur M; Burhan E; Richardus JH
Infect Dis Poverty; 2019 Feb; 8(1):10. PubMed ID: 30709415
[TBL] [Abstract][Full Text] [Related]
6. Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru.
Wingfield T; Boccia D; Tovar M; Gavino A; Zevallos K; Montoya R; Lönnroth K; Evans CA
PLoS Med; 2014 Jul; 11(7):e1001675. PubMed ID: 25025331
[TBL] [Abstract][Full Text] [Related]
7. The economic burden of households affected by tuberculosis in Brazil: First national survey results, 2019-2021.
Noia Maciel EL; Negri LDSA; Guidoni LM; Fregona GC; Johansen FDC; Sanchez MN; Moreira ADSR; Diaz-Quijano FA; Tonini M; Zandonade E; Ershova J; Nguhiu P; Baena IG
PLoS One; 2023; 18(12):e0287961. PubMed ID: 38091306
[TBL] [Abstract][Full Text] [Related]
8. Beyond pills and tests: addressing the social determinants of tuberculosis.
Wingfield T; Tovar MA; Huff D; Boccia D; Saunders MJ; Datta S; Montoya R; Ramos E; Lewis JJ; Gilman RH; Evans C
Clin Med (Lond); 2016 Dec; 16(Suppl 6):s79-s91. PubMed ID: 27956446
[TBL] [Abstract][Full Text] [Related]
9. Catastrophic total costs in tuberculosis-affected households and their determinants since Indonesia's implementation of universal health coverage.
Fuady A; Houweling TAJ; Mansyur M; Richardus JH
Infect Dis Poverty; 2018 Jan; 7(1):3. PubMed ID: 29325589
[TBL] [Abstract][Full Text] [Related]
10. Catastrophic costs incurred by tuberculosis affected households from Thailand's first national tuberculosis patient cost survey.
Youngkong S; Kamolwat P; Wongrot P; Thavorncharoensap M; Chaikledkaew U; Nateniyom S; Pungrassami P; Praditsitthikorn N; Mahasirimongkol S; Jittikoon J; Nishikiori N; Baena IG; Yamanaka T
Sci Rep; 2024 May; 14(1):11205. PubMed ID: 38755216
[TBL] [Abstract][Full Text] [Related]
11. Costs incurred by patients with drug-susceptible pulmonary tuberculosis in semi-urban and rural settings of Western India.
Rupani MP; Cattamanchi A; Shete PB; Vollmer WM; Basu S; Dave JD
Infect Dis Poverty; 2020 Oct; 9(1):144. PubMed ID: 33076969
[TBL] [Abstract][Full Text] [Related]
12. Economic burden of tuberculosis in Tanzania: a national survey of costs faced by tuberculosis-affected households.
Kilale AM; Pantoja A; Jani B; Range N; Ngowi BJ; Makasi C; Majaha M; Manga CD; Haule S; Wilfred A; Hilary P; Mahamba V; Nkiligi E; Muhandiki W; Matechi E; Mutayoba B; Nishkiori N; Ershova J
BMC Public Health; 2022 Mar; 22(1):600. PubMed ID: 35351063
[TBL] [Abstract][Full Text] [Related]
13. Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.
Laurence YV; Griffiths UK; Vassall A
Pharmacoeconomics; 2015 Sep; 33(9):939-55. PubMed ID: 25939501
[TBL] [Abstract][Full Text] [Related]
14. Out-of-pocket payments and economic consequences from tuberculosis care in eastern China: income inequality.
Liu Y; Xu CH; Wang XM; Wang ZY; Wang YH; Zhang H; Wang L
Infect Dis Poverty; 2020 Feb; 9(1):14. PubMed ID: 32019611
[TBL] [Abstract][Full Text] [Related]
15. Cash transfer and microfinance interventions for tuberculosis control: review of the impact evidence and policy implications.
Boccia D; Hargreaves J; Lönnroth K; Jaramillo E; Weiss J; Uplekar M; Porter JDH; Evans CA
Int J Tuberc Lung Dis; 2011 Jun; 15 Suppl 2(Suppl 2):37-49. PubMed ID: 21740658
[TBL] [Abstract][Full Text] [Related]
16. The economic burden of TB diagnosis and treatment in South Africa.
Foster N; Vassall A; Cleary S; Cunnama L; Churchyard G; Sinanovic E
Soc Sci Med; 2015 Apr; 130():42-50. PubMed ID: 25681713
[TBL] [Abstract][Full Text] [Related]
17. Determinants of catastrophic costs among households affected by multi-drug resistant tuberculosis in Ho Chi Minh City, Viet Nam: a prospective cohort study.
Pham TAM; Forse R; Codlin AJ; Phan THY; Nguyen TT; Nguyen N; Vo LNQ; Dat PT; Minh HDT; Nguyen LH; Nguyen HB; Nguyen NV; Bodfish M; Lönnroth K; Wingfield T; Annerstedt KS
BMC Public Health; 2023 Dec; 23(1):2372. PubMed ID: 38042797
[TBL] [Abstract][Full Text] [Related]
18. How affordable is TB care? Findings from a nationwide TB patient cost survey in Ghana.
Pedrazzoli D; Siroka A; Boccia D; Bonsu F; Nartey K; Houben R; Borghi J
Trop Med Int Health; 2018 Aug; 23(8):870-878. PubMed ID: 29851223
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
